Feasibility of MRI-guided transurethral ultrasound for lesion-targeted ablation of prostate cancer.
Anttinen M, Mäkelä P, Suomi V, Kiviniemi A, Saunavaara J, Sainio T, Horte A, Eklund L, Taimen P, Sequeiros RB, Boström PJ.
Anttinen M, et al. Among authors: suomi v.
Scand J Urol. 2019 Oct;53(5):295-302. doi: 10.1080/21681805.2019.1660707. Epub 2019 Sep 26.
Scand J Urol. 2019.
PMID: 31556779
Free article.
Clinical Trial.